Crossmark

Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways

Crossref DOI link: https://doi.org/10.1016/j.aohep.2022.100671

Published Print: 2022-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Vargas-Pozada, Eduardo E.

Ramos-Tovar, Erika

Acero-Hernández, Consuelo

Cardoso-Lezama, Irina

Galindo-Gómez, Silvia

Tsutsumi, Víctor

Muriel, Pablo
Funding

Funding for this research was provided by:

CONACYT
License Information

Text and Data Mining valid from 2022-03-01

Version of Record valid from 2022-01-14
More Information

This article is maintained by: Elsevier

Article Title: Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2022.100671

Content Type: article

Copyright: © 2022 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below